Link to All Articles

Feb 28 2008, 11:43 AM EST
Alticor Backs Interleukin Genetics' Risk Assessment Research
Company will provide $1.2 million for studies that include evaluation of osteoporosis and cardiovascular disease in Asian populations.Full Story

Feb 27 2008, 12:13 PM EST
Scientists Demonstrate Effects of IL-8 Gene Silencing by Liposome-Encapsulated siRNA in Ovarian Cancer
Study published in Journal of the National Cancer Institute also showed that this method can resensitize tumors to taxanes.Full Story

Feb 27 2008, 12:07 PM EST
Genentech Adds Targets to Protein Pharmaceutical Production Deal with Sangamo
Sangamo will design and engineer ZFNs that target genes supplied by Genentech.Full Story

Feb 27 2008, 12:08 PM EST
Sigma-Aldrich and MorphoSys Ally to Supply Research Recombinant Antibodies
MorphoSys' HuCAL GOLD® technology will be used to generate antibodies against novel targets provided by Sigma-Aldrich, which will tackle final distribution.Full Story

Feb 26 2008, 12:13 PM EST
Galderma Offers $420M to Acquire CollaGenex to Pad Dermatology Focus
CollaGenex' oral therapy for rosacea will complement Galderma's topical treatments.Full Story

Feb 26 2008, 12:06 PM EST
Althea Technologies Spins Out Diagnostics Business
New firm will focus on genetic testing services and diagnostic products related to oncology applications.Full Story

Feb 25 2008, 12:54 PM EST
Peptide Identified that Specifically Binds to Tumors Responding to Therapy
Protein fragment linked to a light-emitting molecule was able to pick out tumors in mice two days after treatment, according to Nature Medicine paper.Full Story

Feb 25 2008, 12:56 PM EST
Cypress to Pay $37.5M in Cash Upfront for Proprius Pharmaceuticals
Acquired line of diagnostic and prognostic tools will help the firm advance its therapy for fibromyalgia, which is under FDA review.Full Story

Feb 22 2008, 11:52 AM EST
Warnex Gains Rights from Xenomics to Develop AML Assay
Nonexclusive license agreement covers testing of the NPMI gene mutation linked to the disease.Full Story

GenEngNews.com